A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

Clinical trial NCT07519772 · RECRUITING

Trial details

NCT number: NCT07519772
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse

Start date: 2026-05-03
Primary completion: 2030-07-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.